AGP Executive Report
Last update: 10 hours agoYellow Fever: WHO reports two confirmed cases in the Central African Republic, part of 67 cases and 18 deaths across nine African countries through Oct. 12. Cross-border travel, uneven vaccination and mosquito exposure raise the risk of further spread; WHO rates the regional threat as moderate. Regional Preparedness: The third phase of the West and Central Africa Health Security Programme includes the CAR and aims to strengthen disease surveillance, cooperation and emergency response across borders. HIV Prevention: The US FDA has tentatively approved the first generic long-acting injectable lenacapavir for HIV prevention. Initial supplies are expected before year-end, with wider availability in 2027; the agreed price is $40 per person annually in 120 eligible countries. Ebola Monitoring: As the major Bundibugyo outbreak spreads in the region, CAR health workers are screening travellers at the DRC border, including temperature checks and registration.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
